| CAS登录号 | 中文名 | 英文名 | 分子结构式 | 分子式 | 详情 | 供应商 |
| 78228-88-3 | L-Valine,N-[N2-[N-[N2-(N-L-Lysyl-L-Threonyl)-L-Arginyl]-L-a-Glutamyl]-L-Lysyl]- (9CI); lac repressor fragment 33-38 | ![]() | C32H61N11O10 | 详情 | 供应商 | |
| 152051-61-1 | L-Leucine,L-Lysyl-L-Arginyl-L-Threonylglycyl-L-Glutaminyl-L-tyrosyl-L-Lysyl-; L-Leucine,N-[N2-[N-[N2-[N-[N-(N2-L-Lysyl-L-Arginyl)-L-Threonyl]glycyl]-L-Glutaminyl]-L-tyrosyl]-L-Lysyl]-; 7: PN: US20030229017 PAGE: 13 claimed protein | ![]() | C44H76N14O12 | 详情 | 供应商 | |
| 324029-01-8 | ALA-Arg-Lys-Arg-Glu-Arg-Thr-TYR-SER-PHE-GLY-HIS-HIS-ALA | AKTIDE-2T; ALA-Arg-Lys-Arg-Glu-Arg-Thr-TYR-SER-PHE-GLY-HIS-HIS-ALA; AKTIDE-2T; AKT/PKB/RAC-PROTEIN KINASE SUBSTRATE [ARKRERTYSFGHHA]; ARKRERTYSFGHHA; H-ALA-Arg-Lys-Arg-Glu-Arg-Thr-TYR-SER-PHE-GLY-HIS-HIS-ALA-OH; AKT/PKB/Rac - Protein Kinase Substrate | ![]() | C74H114N28O20 | 详情 | 供应商 |
| 198284-64-9 | GAP 27; H-SER-Arg-PRO-Thr-Glu-Lys-Thr-ILE-PHE-ILE-ILE-OHSER-Arg-PRO-Thr-Glu-Lys-Thr-ILE-PHE-ILE-ILE; GAP 27; M.W. 1304.55 C60H101N15O17 | ![]() | C60H101N15O17 | 详情 | 供应商 | |
| 205640-90-0 | OREXIN A (HUMAN, BOVINE, CANINE, MOUSE, OVINE, PORCINE, RAT) | PYR-PRO-LEU-PRO-ASP-CYS-CYS-Arg-GLN-Lys-Thr-CYS-SER-CYS-Arg-LEU-TYR-Glu-LEU-LEU-HIS-GLY-ALA-GLY-ASN-; HYPOCRETIN; PYR-PRO-LEU-PRO-ASP-CYS-CYS-Arg-GLN-Lys-Thr-CYS-SER-CYS-Arg-LEU-TYR-Glu-LEU-LEU-HIS-GLY-ALA-GLY-ASN-HIS-ALA-ALA-GLY-ILE-LEU-Thr-LEU-NH2; PYR-PRO-LEU-PRO-ASP-CYS-CYS-Arg-GLN-Lys-Thr-CYS-SER-CYS-Arg-LEU-TYR-Glu-LEU-LEU-HIS-GLY-ALA-GLY-ASN-HIS-ALA-ALA-GLY-ILE-LEU-Thr-LEU-NH2 (DISULFIDE BRIDGE: 6-12 AND 7-14); PYR-PLPDCCRQKTCSCRLYELLHAGAGNHAAGILTL-NH2; PYR-PLPDCCRQKTCSCRLYELLHGAGNHAAGILTL-NH2; PYR-PLPDCCRQKTCSCRLYELLHGAGNHAAGILTL-NH2 (DISULFIDE BRIDGE: 6-12 AND 7-14); OREXINS OREXIN A HUMAN, RAT, MOUSE; OREXIN A, BOVINE, HUMAN, MOUSE, RAT | ![]() | C152H247N47O44S4 | 详情 | 供应商 |
| 600171-68-4 | ORPHAN GPCR SP9155 AGONIST P518 (HUMAN) | H-Thr-SER-GLY-PRO-LEU-GLY-ASN-LEU-ALA-Glu-Glu-LEU-ASN-GLY-TYR-SER-Arg-Lys-Lys-GLY-GLY-PHE-SER-PHE-AR; H-Thr-SER-GLY-PRO-LEU-GLY-ASN-LEU-ALA-Glu-Glu-LEU-ASN-GLY-TYR-SER-Arg-Lys-Lys-GLY-GLY-PHE-SER-PHE-Arg-PHE-NH2; ORPHAN GPCR SP9155 AGONIST P518 (HUMAN); ORPHAN G-PROTEIN COUPLED RECEPTOR SP9155 AGONIST PEPTIDE P518 (HUMAN); P518 (HUMAN); Orphan GPCR SP9155 Agonist P518 (huMan) P518 (huMan), Orphan G-Protein Coupled Receptor SP9155 Agonist Peptide P518 (huMan) | ![]() | 详情 | 供应商 | |
| 185032-24-0 | TYR-Lys-GLY-(CYCLO(Glu26-Lys29),PRO34)-NEUROPEPTIDE Y (25-36) | H-TYR-Lys-GLY-Arg-CYCLO(-Glu-TYR-ILE-Lys)-LEU-ILE-Thr-Arg-PRO-Arg-TYR-NH2; H-TYR-Lys-GLY-Arg-CYCLO(-GAMMA-Glu-TYR-ILE-EPSILON-Lys)-LEU-ILE-Thr-Arg-PRO-Arg-TYR-NH2; H-TYR-Lys-GLY-Arg-CYCLO(-Glu-TYR-ILE-Lys)-LEU-ILE-Thr-Arg-PRO-Arg-TYR-NH2; TYR-Lys-GLY-Arg-(Glu26,Lys29,PRO34)-NEURO-PEPTIDE Y (26-36); TYR-Lys-GLY-(CYCLO(Glu26,Lys29),PRO34)-NEUROPEPTIDE Y (25-36); TYR-Lys-GLY-(CYCLO(Glu26,Lys29),PRO34)-NPY (25-36) | ![]() | 详情 | 供应商 | |
| 112540-82-6 | ALA-VAL-SER-Glu-HIS-GLN-LEU-LEU-HIS-ASP-Lys-GLY-Lys-SER-ILE-GLN-ASP-LEU-Arg-Arg-Arg-PHE-PHE-LEU-HIS-HIS-LEU-ILE-ALA-Glu-ILE-HIS-Thr-ALA; ALA-VAL-SER-Glu-HIS-GLN-LEU-LEU-HIS-ASP-Lys-GLY-Lys-SER-ILE-GLN-ASP-LEU-Arg-Arg-Arg-PHE-PHE-LEU-HIS-HIS-LEU-ILE-ALA-Glu-ILE-HIS-Thr-ALA; ALA-VAL-SER-Glu-HIS-GLN-LEU-LEU-HIS-ASP-Lys-GLY-Lys-SER-ILE-GLN-ASP-LEU-Arg-Arg-Arg-PHE-PHE-LEU-HIS-HIS-LEU-ILE-ALA-Glu-ILE-HIS-Thr-ALA-NH2: AVSEHQLLHDKGKSIQDLRRRFFLHHLIAEIHTA-NH2; ALA-VAL-SER-Glu-HIS-GLN-LEU-LEU-HIS-ASP-Lys-GLY-Lys-SER-ILE-GLN-ASP-LEU-Arg-Arg-Arg-PHE-PHE-LEU-HIS-HIS-LEU-ILE-ALA-Glu-ILE-HIS-Thr-ALA: AVSEHQLLHDKGKSIQDLRRRFFLHHLIAEIHTA | H-ALA-VAL-SER-Glu-HIS-GLN-LEU-LEU-HIS-ASP-Lys-GLY-Lys-SER-ILE-GLN-ASP-LEU-Arg-Arg-Arg-PHE-PHE-LEU-HIS-HIS-LEU-ILE-ALA-Glu-ILE-HIS-Thr-ALA-OH; AVSEHQLLHDKGKSIQDLRRRFFLHHLIAEIHTA; AVSEHQLLHDKGKSIQDLRRRFFLHHLIAEIHTA-NH2; H-ALA-VAL-SER-Glu-HIS-GLN-LEU-LEU-HIS-ASP-Lys-GLY-Lys-SER-ILE-GLN-ASP-LEU-Arg-Arg-Arg-PHE-PHE-LEU-HIS-HIS-LEU-ILE-ALA-Glu-ILE-HIS-Thr-ALA-OH; HUMORAL HYPERCALCEMIA OF MALIGNANCY FACTOR, (1-34), HUMAN; HYPERCALCEMIA OF MALIGNANCY FACTOR (1-34) AMIDE (HUMAN, RAT); HYPERCALCEMIA OF MALIGNANCY FACTOR (1-34) HUMAN; HYPERCALCEMIA OF MALIGNANCY FACTOR (1-34) (HUMAN, RAT); HYPERCALCEMIA OF MALIGNANCY FACTOR FRAGMENT 1-34 AMIDE HUMAN | 无 | C180H287N57O48 | 详情 | 供应商 |
| 17998-69-5 | H-Tyr-Pro-Ile-Lys-Pro-Glu-Ala-Pro-Gly-Glu-Asp-Ala-Ser-Pro-Glu-Glu-Leu-Asn-Arg-Tyr-Tyr-Ala-Ser-Leu-Arg-His-Tyr-Leu-Asn-Leu-Leu-Thr-Arg-Pro-Arg-Tyr-NH2 | 无 | 详情 | 供应商 |